Sign Out
Daratumumab is an immunoglobulin G1 kappa (IgG1κ) human monoclonal antibody against CD38 antigen, produced in a mammalian cell line (Chinese Hamster Ovary [CHO]) using recombinant DNA technology.
DARZALEX is available as a colorless to yellow preservative free liquid concentrate for intravenous infusion after dilution.
Each mL contains 20 mg daratumumab.
5 mL vial: Each single-use vial contains 100 mg of daratumumab.
20 mL vial: Each single-use vial contains 400 mg of daratumumab.
Excipients/Inactive Ingredients: L-histidine, L-histidine hydrochloride monohydrate, L-methionine, Polysorbate 20, Sorbitol, Water for injection.
Continue with Google